Over $80 a share? GILD shareholders would vote that down out of hand. Maybe you're talking about some time farther down the road. The only time that would make sense for GILD would be after monotherapy approval and we start eating into their profits. By that time it would be too late. Their sales, earnings would be down substantially and our share price would be the equal of or better than theirs.

GILD had their chance, let them wallow in their stupidity.